This review emphasizes the need for basic research in CTEPH pathophysiology to catch up with the significant advances in medical and surgical treatments.
Answers are grounded in this paper and cite their sources.
CTEPH therapies advance without matching mechanistic insight; leaves open the need for basic research to guide future targets.
The modern treatment era in chronic thromboembolic disease has seen significant advances in both surgical and medical treatment. One such treatment, the pulmonary endarterectomy (where established chronic organized thrombus is removed), has dramatically affected morbidity and mortality. These advances have outstripped basic research into the causes and pathophysiology of disease, which remain largely poorly understood. In this review, we will set out to explain some of the historical reasons for this, including the difficulties inherent in human studies and the lack of good animal models. We will review some of the recent advances in pathophysiology from registries and translational research, and we will summarize the treatment options, with some discussion of very recently published work, including medical and surgical treatments, both traditional and more experimental work in non-invasive techniques.
No takes yet. Share an insight, caveat, or question.
Toshner et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: